Straits Times Index
3,309.14 +9.14 (+0.28%) Nikkei
38,621.34 -11.68 (-0.03%) Hang Seng
18,075.53 -259.79 (-1.42%) FTSE 100
8,272.46 +67.35 (+0.82%) Bitcoin USD
64,545.49 -869.36 (-1.33%) CMC Crypto 200
1,352.91 -29.75 (-2.15%)
HCW Biologics Inc. (HCWB)
- GlobeNewswire
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
MIRAMAR, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2024. Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “We reached an imp
- GlobeNewswire
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its fourth quarter and fiscal year ended December 31, 2023. Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stat
- Simply Wall St.
Rebecca Byam Bought 122% More Shares In HCW Biologics
HCW Biologics Inc. ( NASDAQ:HCWB ) shareholders (or potential shareholders) will be happy to see that the Chief...
